trazodone has been researched along with Neurotic Disorders in 2 studies
Trazodone: A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)
trazodone : An N-arylpiperazine in which one nitrogen is substituted by a 3-chlorophenyl group, while the other is substituted by a 3-(3-oxo[1,2,4]triazolo[4,3-a]pyridin-2(3H)-yl)propyl group.
Neurotic Disorders: Disorders in which the symptoms are distressing to the individual and recognized by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Peruzy, AD | 1 |
De Gregorio, M | 1 |
Favilli, S | 1 |
De Santis, AM | 1 |
Lehmann, HE | 1 |
Ban, TA | 1 |
Schwartz, GV | 1 |
2 trials available for trazodone and Neurotic Disorders
Article | Year |
---|---|
[Statistical study on a new tranquilizing agent].
Topics: Adult; Clinical Trials as Topic; Diazepam; Drug Evaluation; Female; Humans; Male; Neurotic Disorders | 1975 |
Psychotherapeutic profile of a new psychoactive drug trazodone (AF-1161).
Topics: Adult; Aged; Clinical Trials as Topic; Depression; Female; Humans; Male; Mental Disorders; Middle Ag | 1975 |